J&J to Supply EU with up to 400M Doses of its COVID-19 Vaccine

Share this

J&J to Supply EU with up to 400M Doses of its COVID-19 Vaccine


  • EC has approved an advance purchase agreement in which the Janssen will supply 200 M doses of the COVID-19 vaccine candidate to EU member states following approval from regulators. Additionally- the EU member states have an option to secure up to 200M additional doses
  • The agreement follows the conclusion of exploratory talks with the EC. Apart from the agreement- J&J plans to allocate up to 500M vaccine doses toward international efforts for ensuring access in lower income countries- with delivery beginning in mid-2021- following approval
  • J&J is evaluating a single dose regimen in P-III ENSEMBLE study initiated in Sept’2020 and plans the initiation of P-III study with a two-dose regimen later this year

     ­ Ref: J&J | Image: Law.com
Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions